Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Mir133b | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Mir133b (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MIR133B | CTD | PMID:39978740 | Mir133b | Rat | 6-propyl-2-thiouracil | increases expression | ISO | Mir133b (Mus musculus) | 6480464 | Propylthiouracil results in increased expression of MIR133B mRNA | CTD | PMID:20808432 | Mir133b | Rat | amphetamine | increases expression | EXP | | 6480464 | Amphetamine results in increased expression of MIR133B mRNA | CTD | PMID:30779732 | Mir133b | Rat | arsenous acid | increases expression | ISO | MIR133B (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of MIR133B mRNA | CTD | PMID:22072212 | Mir133b | Rat | atorvastatin calcium | multiple interactions | ISO | Mir133b (Mus musculus) | 6480464 | [Buthionine Sulfoximine co-treated with Atorvastatin co-treated with Ciprofloxacin] results in increased expression of MIR133B mRNA | CTD | PMID:29679711 | Mir133b | Rat | benzo[a]pyrene | affects methylation | ISO | MIR133B (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of MIR133B promoter | CTD | PMID:27901495 | Mir133b | Rat | bleomycin A2 | decreases expression | EXP | | 6480464 | Bleomycin results in decreased expression of MIR133B mRNA | CTD | PMID:25933445 | Mir133b | Rat | cadmium atom | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MIR133B more ... | CTD | PMID:33652105 | Mir133b | Rat | cadmium atom | multiple interactions | ISO | Mir133b (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MIR133B more ... | CTD | PMID:28892167 | Mir133b | Rat | cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MIR133B more ... | CTD | PMID:33652105 | Mir133b | Rat | cadmium dichloride | multiple interactions | ISO | Mir133b (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MIR133B more ... | CTD | PMID:28892167 | Mir133b | Rat | ciprofloxacin | multiple interactions | ISO | Mir133b (Mus musculus) | 6480464 | [Buthionine Sulfoximine co-treated with Atorvastatin co-treated with Ciprofloxacin] results in increased expression of MIR133B mRNA | CTD | PMID:29679711 | Mir133b | Rat | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of MIR133B mRNA | CTD | PMID:24880025 | Mir133b | Rat | cisplatin | increases response to substance | ISO | MIR133B (Homo sapiens) | 6480464 | MIR133B mRNA results in increased susceptibility to Cisplatin | CTD | PMID:32052927 | Mir133b | Rat | diarsenic trioxide | increases expression | ISO | MIR133B (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of MIR133B mRNA | CTD | PMID:22072212 | Mir133b | Rat | gemfibrozil | multiple interactions | ISO | Mir133b (Mus musculus) | 6480464 | [Buthionine Sulfoximine co-treated with Lovastatin co-treated with Gemfibrozil] results in increased expression of MIR133B mRNA | CTD | PMID:30853469 | Mir133b | Rat | lovastatin | multiple interactions | ISO | Mir133b (Mus musculus) | 6480464 | [Buthionine Sulfoximine co-treated with Lovastatin co-treated with Gemfibrozil] results in increased expression of MIR133B mRNA | CTD | PMID:30853469 | Mir133b | Rat | methimazole | multiple interactions | ISO | Mir133b (Mus musculus) | 6480464 | [Methimazole co-treated with perchlorate] results in increased expression of MIR133B mRNA | CTD | PMID:20808432 | Mir133b | Rat | nickel atom | multiple interactions | EXP | | 6480464 | [nickel sulfate results in increased abundance of Nickel] which results in increased expression of MIR133B more ... | CTD | PMID:31734292 | Mir133b | Rat | nickel sulfate | multiple interactions | EXP | | 6480464 | [nickel sulfate results in increased abundance of Nickel] which results in increased expression of MIR133B more ... | CTD | PMID:31734292 | Mir133b | Rat | paracetamol | decreases expression | ISO | Mir133b (Mus musculus) | 6480464 | Acetaminophen results in decreased expression of MIR133B mRNA | CTD | PMID:19246379 | Mir133b | Rat | perchlorate | multiple interactions | ISO | Mir133b (Mus musculus) | 6480464 | [Methimazole co-treated with perchlorate] results in increased expression of MIR133B mRNA | CTD | PMID:20808432 | Mir133b | Rat | perfluorooctane-1-sulfonic acid | increases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in increased expression of MIR133B mRNA | CTD | PMID:24420840 | Mir133b | Rat | perfluorooctanoic acid | increases expression | ISO | Mir133b (Mus musculus) | 6480464 | perfluorooctanoic acid results in increased expression of MIR133B mRNA | CTD | PMID:28126411 | Mir133b | Rat | pioglitazone | multiple interactions | ISO | Mir133b (Mus musculus) | 6480464 | [Pioglitazone co-treated with Buthionine Sulfoximine] results in increased expression of MIR133B mRNA | CTD | PMID:28263783 | Mir133b | Rat | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of MIR133B mRNA | CTD | PMID:26432773 | Mir133b | Rat | resveratrol | increases expression | ISO | MIR133B (Homo sapiens) | 6480464 | resveratrol results in increased expression of MIR133B mRNA | CTD | PMID:25605016 | Mir133b | Rat | S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | Mir133b (Mus musculus) | 6480464 | [Buthionine Sulfoximine co-treated with Atorvastatin co-treated with Ciprofloxacin] results in increased expression of MIR133B mRNA; more ... | CTD | PMID:28263783|PMID:29679711|PMID:30853469 | Mir133b | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of MIR133B mRNA | CTD | PMID:27397436 | Mir133b | Rat | titanium dioxide | increases expression | ISO | Mir133b (Mus musculus) | 6480464 | titanium dioxide results in increased expression of MIR133B mRNA | CTD | PMID:21259345 | Mir133b | Rat | valproic acid | increases expression | ISO | Mir133b (Mus musculus) | 6480464 | Valproic Acid results in increased expression of MIR133B mRNA | CTD | PMID:24896083 | Mir133b | Rat | zinc atom | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of MIR133B mRNA | CTD | PMID:22689922 | Mir133b | Rat | zinc(0) | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of MIR133B mRNA | CTD | PMID:22689922 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





















